HNSCC patients with low ABCB1 expression had significantly shorter progression-free survival times and tended to die earlier (overall survival, p = 0.0535) than patients with ABCB1 expression higher than the median (Fig. 2). Here, ABCB1 is linked to head and neck squamous cell carcinoma.